News
A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...
Merck MRK announced that the FDA has accepted for review the new drug application (“NDA”) seeking approval for its ...
There is widespread hope for curbing HIV after the United States Food and Drug Administration (FDA) approved an injectable ...
Government should increase their allocation to the health sector to at least 15 percent of the total National Budget ...
22h
allAfrica.com on MSNFunding crisis threatens progress in fight against HIV/AidsThe report emphasises the urgent need for countries to implement radical changes in their HIV programming and funding ...
23h
The Star on MSNKenya among countries to receive drug given twice-yearly to prevent HIVThe Global Fund has announced that it signed an access agreement with Gilead Sciences to procure lenacapavir, a twice-a-year injection that has a 99 per cent success rate in preventing HIV ...
Explore more
This new FDA-approved shot is designed to break down the barriers that have kept too many people from accessing PrEP.
TRUE or FALSE. Enflonsia (clesrovimab-cfor) is indicated for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants who are born during or entering ...
Bill Gates Warns Of 'Devestating Effects' Of USAID Funding Cuts: 'It's Not Too Late To Reverse Them'
Bill Gates raises concerns over U.S. aid cuts' impact on HIV programs in Africa and calls for a reversal of the decision.
Current operations chief Renee Gala will succeed Bruce Cozadd at Jazz. Meanwhile, a key study of an Ultragenyx and Mereo drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results